Research summary ·
Prevalence of Cancer Across Cardiovascular and Cardiometabolic Conditions: A Systematic Review and Meta-Analysis.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review estimated how common cancer is in heart and metabolic disease. It covered coronary artery disease, heart failure, atrial fibrillation and hypertension. It also covered type 2 diabetes, stroke, peripheral artery disease and valve disease. The main outcome was active cancer. Searches ran from 2010 to July 2024. Prevalence was estimated with mixed models.
What they found
The review included 676 studies. The active cancer analysis used 59 studies. Those covered 4,759,695 patients. Active cancer was least common in type 2 diabetes and most common in atrial fibrillation. Any cancer was least common in coronary artery disease and most common in atrial fibrillation. Any-cancer figures were more mixed in how they were found.
What it means for patients
The authors say cancer is a substantial comorbidity in these conditions. They say the estimates may inform cardio-oncology research, health planning and trial design. They add that the estimates may inform risk stratification.
Why it is not certain yet
Methods to find cancer varied across studies. This was most true for any-cancer figures. The abstract does not give study quality results. This is pooled prevalence, not a test of cause. The abstract does not give how often cancer was found in each group in counts.
Source
Prevalence of Cancer Across Cardiovascular and Cardiometabolic Conditions: A Systematic Review and Meta-Analysis.
PubMed · PMID 42743071We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Atrial fibrillation publications